Related Experiment Video
Updated: Jun 10, 2025
04:46
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Published on: February 24, 2023
1.4K
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Yang Liu1, Fei Zhou1, Heba Ali2
1Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Cellular & Molecular Immunology
|October 15, 2024
Summary
Glioblastoma (GBM) immunotherapy faces challenges due to the brain’s unique immune environment and tumor characteristics. Combination therapies are essential to overcome resistance and improve outcomes for aggressive brain tumors.
Area of Science:
- Neuro-oncology
- Immunology
- Cancer Therapy
Background:
- Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis.
- Current standard treatments offer limited clinical benefit, often leading to tumor recurrence.
- GBM presents unique challenges for immunotherapy due to its immunosuppressive tumor microenvironment and cellular heterogeneity.
Purpose of the Study:
- To review current immunotherapeutic strategies for GBM.
- To discuss mechanisms of immunotherapy resistance in GBM.
- To explore strategies for overcoming resistance, emphasizing combination therapies.
Main Methods:
- Literature review of current immunotherapeutic strategies for Glioblastoma.
- Analysis of molecular mechanisms underlying immunotherapy resistance.
- Discussion of potential combination therapies to enhance treatment efficacy.
Main Results:
- Immunotherapy benefits in GBM are limited by the brain's immune profile and tumor characteristics.
- Understanding GBM heterogeneity and the immunosuppressive microenvironment is crucial.
- Combination therapies show promise for overcoming immunotherapy resistance.
Conclusions:
- Overcoming immunotherapy resistance in Glioblastoma requires addressing its unique biological features.
- Combination therapeutic approaches are likely necessary to improve patient outcomes.
- Further research into novel strategies targeting the GBM tumor microenvironment is warranted.
Keywords:
Adoptive T-cell therapiesGlioblastomaImmune checkpoint inhibitors (ICIs)Immunotherapy combinationOncolytic viral therapiesTumor vaccinesMore Related Videos
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
7.9K
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.4K
Related Concept Videos
01:27Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:29Microorganisms in Medicine and Therapeutics
2
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
2
01:30Cancer Vaccines
342
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342